Overview

NCI Definition: A malignant germ cell neoplasm arising from the testis. It is composed of primitive epithelial cells arranged in solid, papillary, and glandular configurations. Most patients present with a testicular mass, which may be associated with pain. More than half of the patients have metastatic disease at diagnosis. The form of treatment following radical orchiectomy is stage dependent. [1]

Testicular embryonal carcinomas most frequently harbor alterations in CDKN1B, ETV6, CCND2, RAD52, and KRAS [2].

Most Commonly Altered Genes in Testicular Embryonal Carcinoma

CDKN1B Amplification, CCND2 Amplification, ETV6 Amplification, RAD52 Amplification, and KRAS Amplification are the most common alterations in testicular embryonal carcinoma [2].

Top Alterations in Testicular Embryonal Carcinoma

Disease Details

Synonyms
Embryonal Carcinoma of Testis, Embryonal Carcinoma of the Testis
Parent(s)
Testicular Pure Germ Cell Tumor
Children
Stage 0 Testicular Embryonal Carcinoma and Childhood Testicular Embryonal Carcinoma
OncoTree Name
Embryonal Carcinoma
OncoTree Code
EMBCA

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.